| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.03 |